Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who are scheduled to undergo a total proctocolectomy and a pelvic pouch with diverting ileostomy.~Exclusion Criteria:~* Patients who are pregnant.~* Patients with ongoing abdominal abscess.~* Patients with ongoing bacterial peritonitis.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sepraspray (Type: EXPERIMENTAL): Sepraspray Powder applied on the viscera directly under the midline incision followed by incision closure. Sepraspray dose applied was between 2 g and 4 g per patient.
- Control (Type: NO_INTERVENTION): No anti-adhesion treatment used.

Based on this trial design, predict the completion outcome and termination type (if applicable).